There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours. After-hours trades for VistaGen Therapeutics Inc. (VTGN) shows that investor sentiment remained intact, with the stock’s consolidated last price rising by $0.0046, or 3.14%, to $0.1511. The VistaGen Therapeutics Inc. has recorded 33,919 volume in the after hours trading session. Yahoo Finance discussed the stock recently as it posted Vistagen Announces Completion of Last Patient, Last Visit in Phase 1 Clinical Trial of Itruvone (PH10), an Investigational Pherine Nasal Spray for Major Depressive Disorder.
From Robots to Self-Driving Cars: 5 AI Stocks to Consider for Your Portfolio
The artificial intelligence (AI) revolution is already here and it's about to change everything we know about everything. With the global market for AI projected to grow from $137 billion in 2022 to over $1.81 trillion by 2030, there's never been a better time to invest in this burgeoning industry. That's why we've compiled a list of the Top 5 AI Stocks to Buy for 2023. These companies are at the forefront of the AI revolution, and have the potential to deliver huge returns to investors like you.
Get our free report, "Top 5 AI Stocks to Buy for 2023".
This NASDAQ-listed company operates within the Biotechnology industry segment, falling under the Healthcare sector. At the end of the last regular session, the stock closed at $0.15 and fluctuated between $0.1576 as its day high and $0.1424 as its day low. The current market capitalization of VistaGen Therapeutics Inc. is $34.33M. A total of 1.38 million shares were traded on the day, compared to an average of 6.79M shares.
Insider trades can also provide insight into a stock’s future direction. During the recent three months, VTGN has seen 2 BUY and 0 SELL insider trades, representing the acquisition of 10,000 and the disposition of 0 shares. Over the last 12 months, there were 10 BUYs and 1 SELLs from insiders. Insiders purchased 1,225,000 shares during that period but sold 60,000.
In the most recent transaction, GIN JERRY B bought 100,000 shares of VTGN for 0.18 per share on Aug 18. After the transaction, the Director now owns 100,000 company shares. In a previous transaction on Aug 18, GIN JERRY B bought 100,000 shares at 0.18 per share. VTGN shares that Director owns now total 100,000.
Among the insiders who bought shares, Singh Shawn acquired of 600,000 shares on Aug 17 at a per-share price of $0.17. This resulted in the CHIEF EXECUTIVE OFFICER holding 626,234 shares of VTGN after the transaction. In another insider transaction, Adler Reid G. bought 300,000 shares at $0.17 per share on Aug 17. Company shares held by the CHIEF LEGAL OFFICER now total 334,629.
Even though price targets are rarely accurate, they do tend to exert some kind of influence from time to time and are often considered important by markets. According to analysts who have offered 12-month price targets for VTGN in the last 3 months, the mean price target is $0.25 with high estimates of $0.25 and low estimates of $0.25. In terms of 52-week highs and lows, VTGN has a high of $1.79 and a low of $0.08.
As of this writing, VTGN has an earnings estimate of -$0.06 per share for the current quarter. EPS was calculated based on a consensus of 2 estimates, with a high estimate of -$0.04 per share and a lower estimate of -$0.08. The company reported an EPS of -$0.08 in the last quarter, which was -14.30% lower than expectations of -$0.07.
Balance Sheet Annually/Quarterly
In a balance sheet, you can see what assets and liabilities the company has, as well as how much equity investors have invested. These figures can be used to calculate a company’s financial ratios to give investors a better idea of its prospects.
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 2 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for VTGN is Buy with a score of 3.00. A total of 0 analysts rated the stock as Buy while 0 rated it as Overweight while 2 rated it as Hold. Among the other participants, 0 thought the stock was Underweight and 0 thought it should be Sold.